medigraphic.com

2005, Number 1

<< Back Next >>

Rev Mex Anest 2005; 28 (1)

What is your patient self-administrating? Pharmacological interactions of herbal medicine

Covarrubias-Gómez A, Nuche-Cabrera E, Téllez-Isaías M

Language: Spanish
References: 58
Page: 32-42
PDF size: 91.68 Kb.


ABSTRACT

Since its origins, mankind has had the need to cure disease; plants were obviously the first option for this goal. The development of medicine drove the use of herbs to oblivion, even to the point of considering them harmless. However, trends in health beginning in the mid-sixties and early seventies retook herbal medicine and started using herbs as medicine supplements. Herb-drug interactions described subsequently led to the need for government health agencies in charge of regulating this situation. In 1996, the sales of herbal medicine products in the USA were estimated at 1.2 billion dollars. Nowadays, this industry has gained even more acceptance by the general public. This is why a better understanding of interactions between herbs and drugs used in the various areas of medicine is much needed.


REFERENCES

  1. Winslow LC, Kroll DJ. Herbs and medicine. Archives of Internal Medicine 1998; 158:2192-2199.

  2. Sánchez S. Introducción a la técnica quirúrgica. 3 edición. Mendez Editores; 1983: 5-27.

  3. Lyons AS, Petrucelli RJ. Historia de la medicina; 1994: 19-58.

  4. Catalayud J, González A. History of development and evolution of local anesthetics, since the coca leaf. Anesthesiology. 2003; 98: 1503-1508.

  5. Trevelyan J. Herbal medicine. Nurse Times 1993; 89: 36-38

  6. Frate DA, Croom EM, Frate JB. Self-treatment with herbal and other plant-derived remedies: rural Mississippi, 1993. MMWR Morbidity and Mortality Weekly Report 1995: 44: 204-207.

  7. Kassler WJ, Blanc P, Greenblat R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Archives of Internal Medicine 1991; 151: 2281-2288.

  8. Brown JS, Marcy SA. The use of botanicals for health purposes by members of a prepaid health plan. Research Nurse Health 1991; 14: 339-350.

  9. Bauer BA. Herbal therapy: What a clinician needs to know to counsel patients effectively. Mayo Foundation for Medical Education and Research 2000; 75: 835-841.

  10. Merriam-Webster´s Collegiate Dictionary. 10th edition. Springfield, Mass: Merriam-Webster Inc; 1993: 542

  11. Drew AK, Myers SP. Safety issues in herbal medicine: Implications for health professionals. Medical Journal of Australia 1997; 166: 538.541.

  12. Brevoort P. The booming US botanical market: a new overview. Herbalgram 1998; 44: 33-46.

  13. Barret B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. Alternative Therapies. 1999; 5: 40-49.

  14. Hodges PJ, Kam PCA. The peri-operative implications of herbal medicines. Anesthesia 2002; 57: 889-899.

  15. Gunning K. Echinacea in treatment and prevention of upper respiratory tract infections. Western Journal of Medicine 1999; 171: 198-200.

  16. Elasser-Beile U, Willenbacher W. Cytokine production in leukocyte cultures during therapy with Echinacea extract. Journal of clinical Laboratory Analysis 1996; 10: 441-445.

  17. Stimpel M, Proksch A. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharides fractions from the plant Echinacea purpurea. Infection Immunology 1984 2001; 46: 845-849.

  18. Melchart D, Linde K, Fisher P. Echinacea for preventing and treating common cold (Cochrane Review). The Cochrane Library. Issue 1. Oxford update software.

  19. Hoheisel O, Sandberg M. Echinagard treatment shortens the course of common cold: a double blind, placebo controlled clinical trial. European Journal of Clinical Respiration. 1997; 9: 261-268.

  20. Miller MG. Herbal medicines: Selected clinical considerations focusing on known or potential drug-herb interaction. Archives of Internal Medicine 1998; 158: 2200-2211.

  21. Mar C, Brent S. An evidence-based review of the 10 most commonly used herbs. Western Journal of Medicine 1999; 171: 168-191.

  22. Silagy CA, Neil AW. A meta-analysis of the effects of garlic on blood pressure. Journal of Hypertension 1994; 12: 463-468.

  23. Stevinson C, Pitter MH, Ernest E. Garlic for treating hypercholesterolemia. Annals of Internal Medicine 2000; 133: 420-429.

  24. Silagy C, Neil A. Garlic powder as a lipid lowering agent: a meta-analysis. Journal of Royal College of Physicians 1994; 28: 39-45.

  25. Warshafsky S, Kramer RS, Sivak SL. Effect of garlic on total serum cholesterol: a meta-analysis. Annals of Internal Medicine 1993; 119: 599-605

  26. Kiesewetter H, Jung EM. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack. European Journal of Clinical Pharmacology 1993; 45: 333-336.

  27. Burnham BE. Garlic as a possible risk for postoperative bleeding. Plastic and Reconstructive Surgery 1995; 95: 213.

  28. Sastre J, Millan A. A Ginkgo Biloba extract (Egb 761) prevents mithocondrial aging by protecting against oxidative stress. Free Radical Biology and Medicine 1998; 24: 298-304.

  29. Cott J. Natural product formulations available in Europe for psychotropic indication. Psychopharmacology Bulletin 1995; 31: 745-751.

  30. Vale S. Subarachnoid hemorrhage associated with Ginkgo biloba. Lancet. 1998; 352: 36.

  31. Gilbert GJ. Ginkgo biloba. Neurology 1997; 48: 1137.

  32. Muller WE, Rolli M. Effects of the hypercum extract (LI160) in biochemical models of antidepressant activity. Pharmacopsychiatry 1997; 30: 102-107.

  33. Rey JM, Walter G. Hypericum perforatum (St. John´s Wort) in depression: pest or blessing? Medical Journal of Australia. 1998; 169: 583-586.

  34. Linde K, Ramirez G, Melchart D, Paulus A. St. John´s wort for depression – an overview and meta-analysis of randomized clinical trials. British Medical Journal 1996; 313: 253-258.

  35. Woelk H. Benefits and risks of the hypericum extract (LI160): Drug monitoring study with 3250 patients. Journal of Geriatric Psychiatry Neurology 1994; 7: 534-538.

  36. Heck AM, Dewitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. American Journal of Health-System Pharmacy 2000; 57: 1221-1230.

  37. Stevinson C, Ernest E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Medicine 2000; 1: 91-99.

  38. Yeu QY. Safety of St. John´s Wort (Hypericum perforatum). Lancet 2000; 355: 576-577.

  39. Johne A. Pharmacokinetic interaction of digoxin with a herbal extract from St. John´s Wort. Clinical Pharmacology Therapeutics 1999; 66: 338-345.

  40. Ang-Lee M, Moss J, Chun-Su Y. Herbal medicines and peri-operative care. Journal of American Medical Association. 2001; 286: 208-216.

  41. Drew A. Herbal medicines: Ma huang. Current Therapeutics 2000: 82-83.

  42. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. American Journal of Health System Pharmacology 2000; 57: 963-969.

  43. Haller C, Benowitz N. Adverse cardiovascular and central nervous system event associated with dietary supplements containing ephedra alkaloids. New England Journal of Medicine 2000; 343: 1833-1838.

  44. Zaacks SM, Klein L, Tan CD, Rodriguez ER, Leikin JB. Hypersensitivity myocarditis associated with ephedra use. Journal of Clinical Toxicology 1999; 37: 485-489.

  45. Chanwai LG. Kava toxicity. Emergency Medicine 2000; 12: 142-145.

  46. Pepping J. Kava: Piper methysticum. American Journal of Health System Pharmacy 1999; 56: 957-960.

  47. Brumley C. Herbs in the peri-operative patient. American Operating Room Nurse Journal 2000; 72: 785-796.

  48. Kane GC, Lipsky JJ. Drug-grapefruit interactions. Mayo Clinic Proceedings 2000; 75: 933-942

  49. Niggeman B, Gruber C. Side-effects of complementary alternative medicine. Allergy 2003; 58: 707-716.

  50. Barret B, Keifer D, Rabago D. Assessing the risk and benefits of herbal medicine: An overview of scientific evidence. Alternative Therapies 1999; 5: 40-49.

  51. Langner EL, Greifenberg S, Gruenwald J. Ginger: history and use. Advances in Natural Therapy 1998; 15: 25-44.

  52. Grant KL, Lutz RB. Ginger. American Journal of Health System Pharmacy 2000; 57: 933-942.

  53. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized controlled clinical trials. British Journal of Anesthesia 2000; 84: 367-371.

  54. Koo KL, Ammit AJ, Tran VH, Duke CC, Roufogalis BD. Gingerols and related analogues inhibit arachidonic acid human platelets serotonin release and aggregation. Thrombosis Research 2001; 103: 387-397.

  55. Leak JA. Peri-operative considerations in the management of the patient taking herbal medicines. Current Opinion in Anesthesiology 2000; 13: 321-325.

  56. Leak JA. Herbal medicines: What do we need to know? American Society of Anesthesiologists Newsletter 2000. (http://www.asahq. org/newsletter/2000/02-00/herbal0200.htlm).

  57. Adusumilli PS, Ben-Porat L, Pereira M, Roesler D, Leitman IM. The prevalence and predictors of herbal medicine in US surgical patients. Journal of the American College of Surgeons 2004; 198: 583-590.

  58. Taddei-Bringas GA, Santillana-Macedo MA, Romero-Cancio JA, Romero-Tellez MB. Aceptación y uso de la herbolaria en medicina familiar. Salud Pública en México 1999; 41: 216-220.




2020     |     www.medigraphic.com